These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 20803239

  • 1. The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis.
    Martiny-Baron G, Holzer P, Billy E, Schnell C, Brueggen J, Ferretti M, Schmiedeberg N, Wood JM, Furet P, Imbach P.
    Angiogenesis; 2010 Sep; 13(3):259-67. PubMed ID: 20803239
    [Abstract] [Full Text] [Related]

  • 2. The Pyrazolo[3,4-d]pyrimidine-Based Kinase Inhibitor NVP-BHG712: Effects of Regioisomers on Tumor Growth, Perfusion, and Hypoxia in EphB4-Positive A375 Melanoma Xenografts.
    Neuber C, Tröster A, Löser R, Belter B, Schwalbe H, Pietzsch J.
    Molecules; 2020 Nov 03; 25(21):. PubMed ID: 33153234
    [Abstract] [Full Text] [Related]

  • 3. EphB4 forward signalling mediates angiogenesis caused by CCM3/PDCD10-ablation.
    You C, Zhao K, Dammann P, Keyvani K, Kreitschmann-Andermahr I, Sure U, Zhu Y.
    J Cell Mol Med; 2017 Sep 03; 21(9):1848-1858. PubMed ID: 28371279
    [Abstract] [Full Text] [Related]

  • 4. Forward EphB4 signaling in endothelial cells controls cellular repulsion and segregation from ephrinB2 positive cells.
    Füller T, Korff T, Kilian A, Dandekar G, Augustin HG.
    J Cell Sci; 2003 Jun 15; 116(Pt 12):2461-70. PubMed ID: 12734395
    [Abstract] [Full Text] [Related]

  • 5. EphrinB2/EphB4 signaling regulates non-sprouting angiogenesis by VEGF.
    Groppa E, Brkic S, Uccelli A, Wirth G, Korpisalo-Pirinen P, Filippova M, Dasen B, Sacchi V, Muraro MG, Trani M, Reginato S, Gianni-Barrera R, Ylä-Herttuala S, Banfi A.
    EMBO Rep; 2018 May 15; 19(5):. PubMed ID: 29643120
    [Abstract] [Full Text] [Related]

  • 6. Ephrin B2 and EphB4 selectively mark arterial and venous vessels in cerebral arteriovenous malformation.
    Bai J, Wang YJ, Liu L, Zhao YL.
    J Int Med Res; 2014 Apr 15; 42(2):405-15. PubMed ID: 24517927
    [Abstract] [Full Text] [Related]

  • 7. The critical role of the interplays of EphrinB2/EphB4 and VEGF in the induction of angiogenesis.
    Du E, Li X, He S, Li X, He S.
    Mol Biol Rep; 2020 Jun 15; 47(6):4681-4690. PubMed ID: 32488576
    [Abstract] [Full Text] [Related]

  • 8. The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction, modulates angiogenesis, and inhibits tumor growth.
    Kertesz N, Krasnoperov V, Reddy R, Leshanski L, Kumar SR, Zozulya S, Gill PS.
    Blood; 2006 Mar 15; 107(6):2330-8. PubMed ID: 16322467
    [Abstract] [Full Text] [Related]

  • 9. NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.
    Tröster A, Heinzlmeir S, Berger BT, Gande SL, Saxena K, Sreeramulu S, Linhard V, Nasiri AH, Bolte M, Müller S, Kuster B, Médard G, Kudlinzki D, Schwalbe H.
    ChemMedChem; 2018 Aug 20; 13(16):1629-1633. PubMed ID: 29928781
    [Abstract] [Full Text] [Related]

  • 10. PDGFRβ reverses EphB4 signaling in alveolar rhabdomyosarcoma.
    Aslam MI, Abraham J, Mansoor A, Druker BJ, Tyner JW, Keller C.
    Proc Natl Acad Sci U S A; 2014 Apr 29; 111(17):6383-8. PubMed ID: 24733895
    [Abstract] [Full Text] [Related]

  • 11. Targeting receptor tyrosine kinase EphB4 in cancer therapy.
    Chen Y, Zhang H, Zhang Y.
    Semin Cancer Biol; 2019 Jun 29; 56():37-46. PubMed ID: 28993206
    [Abstract] [Full Text] [Related]

  • 12. EphB4/ TNFR2/ERK/MAPK signaling pathway comprises a signaling axis to mediate the positive effect of TNF-α on osteogenic differentiation.
    Zhang Y, Yang C, Ge S, Wang L, Zhang J, Yang P.
    BMC Mol Cell Biol; 2020 Apr 16; 21(1):29. PubMed ID: 32299362
    [Abstract] [Full Text] [Related]

  • 13. Multitargeting strategy using lenvatinib and golvatinib: maximizing anti-angiogenesis activity in a preclinical cancer model.
    Nakazawa Y, Kawano S, Matsui J, Funahashi Y, Tohyama O, Muto H, Nakagawa T, Matsushima T.
    Cancer Sci; 2015 Feb 16; 106(2):201-7. PubMed ID: 25458359
    [Abstract] [Full Text] [Related]

  • 14. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
    Noren NK, Lu M, Freeman AL, Koolpe M, Pasquale EB.
    Proc Natl Acad Sci U S A; 2004 Apr 13; 101(15):5583-8. PubMed ID: 15067119
    [Abstract] [Full Text] [Related]

  • 15. Ephrin B2/EphB4 pathway in hepatic stellate cells stimulates Erk-dependent VEGF production and sinusoidal endothelial cell recruitment.
    Das A, Shergill U, Thakur L, Sinha S, Urrutia R, Mukhopadhyay D, Shah VH.
    Am J Physiol Gastrointest Liver Physiol; 2010 Jun 13; 298(6):G908-15. PubMed ID: 20338920
    [Abstract] [Full Text] [Related]

  • 16. Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation but not early vascular development.
    Cowan CA, Yokoyama N, Saxena A, Chumley MJ, Silvany RE, Baker LA, Srivastava D, Henkemeyer M.
    Dev Biol; 2004 Jul 15; 271(2):263-71. PubMed ID: 15223333
    [Abstract] [Full Text] [Related]

  • 17. Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis.
    Djokovic D, Trindade A, Gigante J, Badenes M, Silva L, Liu R, Li X, Gong M, Krasnoperov V, Gill PS, Duarte A.
    BMC Cancer; 2010 Nov 23; 10():641. PubMed ID: 21092311
    [Abstract] [Full Text] [Related]

  • 18. EphB4 signaling is capable of mediating ephrinB2-induced inhibition of cell migration.
    Sturz A, Bader B, Thierauch KH, Glienke J.
    Biochem Biophys Res Commun; 2004 Jan 02; 313(1):80-8. PubMed ID: 14672701
    [Abstract] [Full Text] [Related]

  • 19. Vascular endothelial growth factor-A inhibits EphB4 and stimulates delta-like ligand 4 expression in adult endothelial cells.
    Yang C, Guo Y, Jadlowiec CC, Li X, Lv W, Model LS, Collins MJ, Kondo Y, Muto A, Shu C, Dardik A.
    J Surg Res; 2013 Jul 02; 183(1):478-86. PubMed ID: 23394931
    [Abstract] [Full Text] [Related]

  • 20. EphrinB2/EphB4 Signaling Regulates DPSCs to Induce Sprouting Angiogenesis of Endothelial Cells.
    Gong T, Xu J, Heng B, Qiu S, Yi B, Han Y, Lo ECM, Zhang C.
    J Dent Res; 2019 Jul 02; 98(7):803-812. PubMed ID: 31017515
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.